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INTRODUCTION
Resistance training (RT) is often prescribed to elderly to prevent or reverse age-related loss in skeletal muscle size and function that could jeopardize independent living and quality of life (McLeod et al., 2016) . Unfortunately, the hypertrophic response to RT seems to be blunted or delayed in the elderly population (Mero et al., 2013; Petrella et al., 2006; Welle et al., 1996) . The complete mechanism behind this delayed response remains unknown, but it has been suggested that impaired ribosome biogenesis and translational efficacy (Brook et al., 2016; Kirby et al., 2015) , deficits in anabolic hormones (Brook et al., 2016) , low-grade inflammation (Alturki et al., 2018) and lower fibre capillarization (Snijders et al., 2017) when getting older may play a role. The efficacy of myonuclear addition in response to an anabolic stimulus could be crucial for increasing the transcriptional capacity (Chaillou, 2017) and the delayed incorporation of new myonuclei in response to training in older adults has been linked to differential myofibre growth between young and old (Petrella et al., 2006) . It has to be determined, though, whether the myonuclear incorporation itself is impaired in elderly or whether this is a consequence of the age-related anabolic resistance. Additionally, older individuals are more prone to discontinuing training programs due to illness, injury, extended traveling or caring for a loved one (Burton et al., 2017) , leading to a loss of the training adaptations. Therefore, RT programs promoting long-lasting effects during detraining or a rapid return to pre-detraining levels once training is resumed, would be of value for the elderly population.
The phenomenon where a previous RT period facilitates rebuilding muscle strength and muscle mass during retraining has been repeatedly reported in humans (Henwood and Taaffe, 2008; Staron et al., 1991) and rodents (Lee et al., 2016) and has been attributed to remaining neural adaptations (i.e. motor learning) (Taaffe and Marcus, 1997) . As solely motor learning did not seem satisfactory to explain rapid fibre growth during retraining, other cell-intrinsic mechanisms have been explored. Nearly ten years ago, it was proposed that once myonuclei are acquired through a first hypertrophic stimulus, they are not lost during muscle atrophy and thus serve as a possible memory during subsequent overloading (Bruusgaard et al., 2010; Gundersen, 2016) . This model has been supported by rodent studies using surgically-or mechanically-induced atrophy (Aravamudan et al., 2006; Bruusgaard et al., 2012; Bruusgaard and Gundersen, 2008; Wada et al., 2002) and studies linking the retained myonuclei to a greater degree of muscle hypertrophy during recurrent overload (Egner et al., 2013; Lee et al., 2018) . Nevertheless, acquired myonuclei do not seem resistant to longer periods of inactivity, as recent studies in mice and humans Psilander et al., 2019; Snijders et al., 2019) report that the myonuclear number returned to the untrained state following, respectively, twelve weeks, twenty weeks and one year of training cessation. This challenges the concept of a muscle memory within the number of myonuclei on the long-term and urges to search for other muscle memory mechanisms, such as lasting J o u r n a l P r e -p r o o f 5 respectively. Drop-out was due to health-related problems (n = 3), injury (n = 2), problems with the dynamometer (n = 1) or a compliance rate below 80 % during the retraining period (n = 1). Furthermore, we will only present fibre characteristics of the CTR group at week 0, 12 and 24, as there was only one muscle sample available at week 36. One subject decided to withdraw from the muscle biopsy procedure and one sample was too small to perform histological analyses. 1RM test on the leg press was performed every four weeks, as depicted by the blue leg press image. The images of a muscle represent the time points at which muscle biopsies were taken. Following training and retraining, muscle biopsy collection was performed ~72 h after the last RT session. The images of a red leg extension machine represent the time points when knee extension strength and power were measured (24 to 48 h after biopsies were taken). The number of subjects (n) engaging in each particular measurement is reflected in the box next to the image of the measurement (grey box: exercise group, EXE; white box: control group, CTR).
J o u r n a l P r e -p r o o f seated on a 45° inclined leg press machine (Signature Series Plate Loaded Linear Leg Press, Life Fitness, Barendrecht, the Netherlands). A warm-up of eight repetitions at 50 % of their estimated 1RM and three repetitions at 70 % of their estimated 1RM was provided. Subsequently, subjects performed one-repetition attempts until failure. When successfully executed, load was increased with 5 to 20 kg, depending on the ease of execution. A resting period of one to three minutes was given between attempts. The heaviest load successfully lifted was considered as the current 1RM.
After the first training period, subjects were asked to resume normal physical activities from before the start of the study and not to engage in strength exercises for twelve weeks. To verify this, subjects weekly filled in a physical activity diary.
The twelve-week detraining period was followed by a twelve-week retraining phase, using the same RT program with starting loads of each exercise adapted to the physical state at that time.
Knee extension strength and power measurements
Knee extension strength and power measurements were assessed using a Biodex Medical System 3® dynamometer (Biodex Medical Systems, Shirley, NY, USA) with chair and lever settings as previously described (Van Roie et al., 2013 ). The precise timing of the measurements is presented in Fig. 1 . Prior to the tests, subjects cycled during 10 min at a light to moderate intensity to warm-up. The protocol consisted of isometric, isotonic and isokinetic tests of the right leg.
Static knee extension strength was assessed at a knee joint angle of 90°. Subjects performed four maximal isometric contractions during 5 s with a 20-s rest interval in between. The isotonic tests were performed against a resistance of 20 % of the individual maximal peak torque at 90°. Subjects were instructed to extend their leg as fast as possible for the full range of motion (90° to 20°), after which to passively flex to the 90° position. This test was performed four times. During the isokinetic test, subjects needed to perform four consecutive explosive extension-flexion movements at a fixed speed of 60 °/s. Torque and velocity signals were sampled at 100 Hz and were processed offline using Matlab (Matlab 2017b, The MathWorks Inc., Natick, Massachusetts, United States). For the isometric tests, static peak torque (Nm) was defined as the highest average torque over a 500 ms epoch and reported as SPT. For the isotonic tests, instantaneous power (watt) was calculated as the product of torque (Nm) and velocity (rad/s). Peak power (PP, w) was defined as the highest value of J o u r n a l P r e -p r o o f In a subset of the subjects, muscle biopsies were taken from the mid-portion of the m. vastus lateralis under local anaesthesia with a 5-mm Bergström needle before training, after training, after detraining and after retraining ( Fig. 1 ).
After extraction, muscle samples were immediately aligned, embedded in Optimum Cutting Temperature compound (Tissue-Tek, Sakura Finetek, USA), frozen in liquid nitrogen-cooled isopentane and stored at -80°C until further analysis.
Before and after training, biopsies were taken from the left leg, whereas biopsies after detraining and retraining were taken from the right leg. This design was chosen to ensure that all biopsies came from the mid-region of the muscle, as biopsy sites were spaced at least 3 cm from each other (Van Thienen et al., 2014) . We assumed that the variance between biopsies from different legs is comparable to the variance between biopsies within the same muscle (Lexell and Taylor, 1991) . Subjects were asked not to participate in moderate to vigorous physical activity in the 24 h before biopsy collection.
Histological and image analyses
Fibre type, fibre type-specific satellite cells (SCs) and myonuclei staining protocols were adapted from (Bergmeister et al., 2016) , (Nederveen et al., 2016) and (Winje et al., 2018) , respectively, and are described in detail in Appendix A.
A combination of myosin heavy chain (MHC)-I (DSHB Cat# BA-F8, RRID:AB_10572253, dilution 1:50), MHC-IIa (DSHB Cat# SC-71, RRID: AB_2147165, dilution 1:200), MHC-IIx (DSHB Cat# 6H1, RRID: AB_1157897, dilution 1:100) and laminin (Thermo Fisher Scientific Cat# PA1-16730, RRID: AB_2133633, dilution 1:250) antibodies was used for fibre typing and fibre size determination. Quantification of fibre type distribution, minimum Feret diameter and crosssectional area (CSA) was performed with Myovision Basic (Wen et al., 2018) based on 267 ± 66 (mean ± SD) fibres per biopsy ( Fig. 2a ). We analysed both minimum Feret diameter and CSA. While CSA is more often reported in literature, the minimum Feret diameter is less influenced by the sectioning angle (Briguet et al., 2004) . We report no systematic error when cutting cryosections or choosing regions for fibre CSA analysis, as patterns and statistical results are very similar between minimum Feret diameter ( Fig. A1 in Appendix A) and CSA (section 3.2.). Myovision output was manually inspected for misidentified fibres or misspecified fibre types. As the numbers of type IIax and IIx fibres were limited or non-existing in some subjects, reports of type II fibre characteristics represent all subtypes of type II fibres (type IIa, IIax, IIx). Fibre type distribution within type II fibres per muscle sample is presented in Table A2 (Appendix A). Fibre-type specific SC counting was facilitated by co-staining with Pax7 (DSHB cat# PAX7, RRID: AB_528428, dilution 1:3), laminin and MHC-I antibodies. SCs were identified as Pax7+ cells containing a nucleus (visualized with Hoechst) ( Fig. 2b) . When not clear to which fibre the identified SC belonged, each fibre received half of the count. Fibre-type specific Pax7+ SC number was manually counted in 358 ± 73 fibres per biopsy in a blind manner.
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To determine fibre-type specific myonuclei, muscle cross-section were stained with primary antibodies against PCM1 (Sigma-Aldrich cat# HPA023370, RRID: AB_1855072, dilution 1:1000) and MCH-1, followed by incubation with the appropriate secondary antibodies and wheat germ agglutinin Alexa Fluor 647 conjugate (Thermo Fisher Scientific, W32466, dilution 1:100). Nuclei were visualized with Hoechst and its co-localization with PCM1 was used to identify myonuclei ( Fig. 2c ). When not clear to which fibre the identified myonucleus belonged, it was not counted. We selected 132 ± 8 fibres with a minimum of 50 fibres per fibre type (Mackey et al., 2009) to determine myonuclear number per fibre. The myonuclear domain (MND, i.e. muscle fibre CSA per myonucleus in muscle biopsy cross-sections (Karlsen et al., 2019) , µm²), was calculated by dividing the CSA of these fibres by the myonuclear number. The investigator was blinded for both subject and time point coding during counting.
All images were captured with a Zeiss AxioObserver Z1 Fluorescence Microscope with a 10x objective for fibre typing and Pax7+ SC content and a 20x objective for myonuclear content, using Zen blue software from Zeiss.
Statistical analyses
Data were analysed with IBM SPSS Statistics 25 (SPSS Inc., Chicago, IL). All values in text and tables are given as mean ± SD, unless otherwise noted. To test for within-and between-group effects of the training, detraining and retraining protocol on muscle strength, fibre size, fibre type, Pax7+ SC number and myonuclear content, we used linear mixed models with time (week 0, 12, 24 and 36) and group (EXE, CTR) as categorical fixed factors. As linear mixed models can handle missing data using restricted maximum likelihood, subjects with missing data points (see Fig. 1 ) were included in the analysis. To account for the correlation between repeated measures, compound symmetry, compound symmetry heterogeneous or unstructured was chosen as repeated covariance type. For each dependent variable, a likelihood ratio test was used to tests the goodness of fit between the different models to determine the correct covariance type. Fisher 
RESULTS

Knee extension strength and power
Twelve weeks of high-load RT significantly increased all knee extension strength and power parameters in the EXE group (+10 to +36 %, p < 0.001) ( Fig. 3) . Cessation of the training for twelve weeks resulted in only modest loss of muscle strength and power (-5 to -15 %, p ≤ 0.004) with the exception of SPT, which approached baseline level again (p = 0.061) (Fig. 3a) . The retraining period restored strength and power parameters back to post-training level (+4 to +24 % compared to post-detraining, p ≤ 0.011), but no additional gains were observed for SPT (p = 0.083), PP (p = 0.845) and IKPT (p = 0.725) ( Fig. 3a-c) . For 1RM dynamic strength, strength levels at eight (p = 0.028) and twelve (p < 0.001) weeks of retraining were significantly higher compared to post-training ( Fig. 3d ). In the CTR group, we observed no significant changes in knee extension strength and power over time (p ≥ 0.098), despite a trend towards less PP in week 36 compared to week 24 (p = 0.098) ( Fig. 3a-c ). There were also no strength differences between the EXE and CTR groups over time (p ≥ 0.069), although a trend was observed at baseline for SPT (p = 0.072) and IKPT (p = 0.069) towards a stronger CTR group. There were no differences between subjects of whom we did and did not take muscle biopsies (p ≥ 0.229) ( Fig 
Muscle fibre size and muscle type distribution
In the EXE group, the first training period did not elicit any significant changes in type I or II CSA (p ≥ 0.665) ( Fig. 5a ).
Despite the lack of a training effect on fibre size, the first training period decreased the percentage of type IIax fibres by half (p = 0.034), which was maintained during detraining and retraining (Fig. 6 ). There was also a trend towards less type IIx fibres post-detraining (p = 0.058) and post-retraining (p = 0.058) compared to baseline (Fig. 6 ). Following the detraining period, a trend was observed towards smaller type II fibres compared to post-training (-17 ± 23 %, p = 0.087) ( Fig. 5a ), resulting in a shift to the left in the fibre size distribution of detrained type II fibres (Fig. 5b) . When type IIa fibres were analysed separately, a significant reduction was observed in type IIa fibre size following detraining compared to post-training (-20 ± 21 %, p = 0.025). Type I fibre size remained unaffected following detraining (p = 0.357) (Fig. 5a ).
J o u r n a l P r e -p r o o f respectively) ( Fig. 5a, 6 ). We observed a trend towards more type IIx fibres at week 24 compared to week 12 (p = 0.080) and the percentage of type IIx fibres at week 24 was significantly higher in the CTR group compared to the EXE group (p = 0.043) (Fig. 6) . 
Pax7+ satellite cells
Following training, a trend was observed towards increased Pax7+ SCs in type I fibres (+49 ± 60 %, p = 0.093) ( Fig. 7) .
Furthermore, there was a strong relationship between changes in Pax7+ SC number and CSA in type II fibres following training (r = 0.77) ( Fig. C1 in Appendix C). Detraining was associated with a trend towards a decrease in the number of Pax7+ SCs in type II fibres (-35 ± 20 %, p = 0.096), whereas the type I Pax7+ SC number remained stable (p = 0.343).
Retraining promoted a significant increase in Pax7+ SCs in both type I (+31 ± 35 %, p = 0.049) and type II fibres (+72 ± 48 %, p = 0.036) (Fig. 7) . Individual subject values of type II Pax7+ SC number are displayed in Fig. 4c . In the CTR group, Pax7+ SC number remained stable over time in both type I and type II fibres (p ≥ 0.173) (Fig. 7) . Within-EXE time effect: significantly different from the indicated time point at the level of: # p ≤ 0.01, ∆ p ≤ 0.05. There were no significant differences within CTR. Between-group effect: there were no significant differences between EXE and CTR.
Myonuclear number and domain
Myonuclear number remained unaltered following the first training period in the EXE group (p ≥ 0.348) (Fig. 8a) . Twelve weeks of detraining, however, significantly decreased the number of myonuclei in type I fibres by -7 ± 5 % (p = 0.008) and also in type II fibres, a similar trend was observed (-12 ± 16 %, p = 0.084) (Fig. 8a) . A significant increase in type II fibre size and type II Pax7+ SC content following retraining was associated with a higher myonuclear number (+13 ± 12 %, p = 0.048) per type II fibre (Fig. 8a , individual data in Fig. 4d ). The myonuclear number in the CTR group remained unchanged over time (p ≥ 0.200) ( Fig. 8a) . At baseline, the number of myonuclei in type I fibres was significantly lower in the CTR group compared to the EXE group (p = 0.025) ( Fig. 8a) , whereas the MND in type II fibres was higher (p = 0.034) (Fig. 8b) . The MND of both the CTR and EXE group remained stable throughout the whole intervention period (p ≥ 0.305) ( Fig. 8b ), suggesting that changes in myonuclear content in the EXE group seem to follow type II fibre size adaptations. Accordingly, we found a relationship between changes in myonuclear number and CSA over time in type II fibres (r = 0.73 following training, r = 0.42 following detraining, r = 0.40 following retraining) and type I fibres (r = 0.79 following training, r = 0.44 following detraining, r = 0.18 following retraining) in the EXE group ( Fig. C1 
DISCUSSION
The hypothesis that a muscle memory is residing within the myonuclei (Gundersen, 2016) , was recently questioned as RT-induced elevated myonuclear number decreased to the untrained state after long-term training cessation in both mice and older humans Psilander et al., 2019; Snijders et al., 2019) . Needing more evidence in humans, we investigated myonuclear behaviour during training, detraining and retraining by staining crosssections of m. vastus lateralis in older men with the myonuclei-specific label PCM1. As there was no significant J o u r n a l P r e -p r o o f strength and power and fibre type changes were not completely lost after twelve weeks of detraining, allowing for a fast recovery of the 1RM performance to post-training levels following retraining.
Twelve weeks of high-intensity training effectively increased muscle strength and power parameters in thirty older men.
When compared with other studies using a RT-protocol of similar intensity and duration in older men, strength gains were similar for SPT (+6 to +11 % vs. +10 ± 14 % in the present study ) (Onambélé-Pearson et al., 2010; Van Roie et al., 2013) , higher for IKPT (+6 to 10% vs. +15 ± 14 % in the present study) (Frontera et al., 1988; Van Roie et al., 2013) , lower for PP (+17 to +19 % vs. +13 ± 21 % in the present study) (Marsh et al., 2009; Sayers and Gibson, 2014) and within the expected range for 1RM (+25 to +107 % vs. +36 ± 11 % in the present study) (Frontera et al., 1988; Marsh et al., 2009; Onambélé-Pearson et al., 2010; Van Roie et al., 2013) . It is known that the 1RM performance tends to improve more than isokinetic strength and functional strength parameters following heavy-RT (Frontera et al., 1988; Lexell et al., 1995) . The difference in gain between leg press 1RM (+36 %) and IKPT (+15 %) in the present study is probably due to neural adaptations specific to the type of training, as the leg press was part of the RT program. Despite a significant increase in muscle strength, the EXE group never outperformed the CTR group, as there was a trend towards a stronger CTR group at baseline. This could be due to the difference in the age range between both groups with the oldest individual being 72 years in the CTR group in contrast to 77 years in the EXE group. In addition, subjects were not randomized due to the intensive protocol and the demand for long-term involvement.
Following twelve weeks of detraining, we observed significant reductions in the muscle strength and power measurements in the EXE group. Strength and power levels post-detraining were, however, still elevated compared to baseline levels, an outcome that has often been described in literature (Hakkinen et al., 2000; Henwood and Taaffe, 2008; Lexell et al., 1995) . Fortunately, it can take more than three times the initial RT period to lose all gained strength (Ivey et al., 2000) . The maintenance of strength gains during detraining has been attributed to lasting neural adaptations, as muscle size returns more rapidly to pre-trained levels during detraining (Hakkinen et al., 2000; Taaffe and Marcus, 1997; Van Roie et al., 2017) . Only SPT approached baseline levels again, which might be explained by the modest response to the first RT period. Limited data exists on detraining-induced loss of PP in elderly, although power declines earlier and more rapidly than muscle strength while aging (Lauretani et al., 2020) and is considered a good determinant of physical functioning in older adults (Reid and Fielding, 2012) . We report a loss of -6 ± 11 % in PP following twelve weeks of detraining in older men. In comparison, twenty-four weeks of detraining following 24 weeks of RT was associated with a decline in power of -15.5 ± 2.2 % (Henwood and Taaffe, 2008) and power remained raised compared to baseline until eight months of detraining (Fatouros et al., 2005) .
J o u r n a l P r e -p r o o f may therefore be less than the first training period (Lexell et al., 1995) . For 1RM strength, only eight weeks of retraining were needed to ameliorate the post-training performance. This result is in agreement with earlier work (Henwood and Taaffe, 2008; Staron et al., 1991) and has been attributed to a form of muscle memory, both at the neural (Taaffe and Marcus, 1997) and cellular (Bruusgaard et al., 2010; Gundersen, 2016) level. With longer periods of detraining, e.g. one
year of detraining, an equal number of weeks as the first training period was necessary during retraining to achieve similar 1RM increases (Correa et al., 2016) . Obviously, the extent of the retention depends on the length of the initial training period and the detraining period. Following two years of training in older adults, for example, dynamic strength gains were not entirely lost even after three years of detraining (Smith et al., 2003) . Why 1RM further increased following retraining in the present study, while SPT, PP and IKPT did not, is not entirely clear. We speculate that the initial strength and power improvements during training were mainly the result of improved connective tissue biomechanics and an increased force generating capacity of the individual fibres (Barry and Carson, 2004) . Further refinement of the motor skill coordination for the leg press exercise could have contributed to additional improvements in 1RM following retraining, which is not necessarily transferrable to other strength tasks. Furthermore, deficiencies in the aged neuromuscular system could also limit the transfer of increased muscle force control beyond the leg press exercise (Barry and Carson, 2004) .
While it has been proven that aged muscle is still able to increase its size to a similar degree as its younger counterpart (Hakkinen et al., 1998; Roth et al., 2001) , there have been reports of attenuated hypertrophic responses in elderly (Mero et al., 2013; Petrella et al., 2006; Welle et al., 1996) . Nevertheless, we expected that twelve weeks of high-intensity RT, designed according to the recommended dosage for elderly (Fragala et al., 2019) , would be sufficient to induce significant fibre size changes in older men, since various studies in elderly report fibre size increases after ten to twelve weeks training (Frontera et al., 1988; Hakkinen et al., 1998; Verdijk et al., 2009) . In contrast with our hypothesis, there was no significant fibre growth in the EXE group following twelve weeks of training. At the individual level, we observed four out of six subjects with an increase in type II fibre cross-sectional area of +11 to +38 % following training and two subjects with opposite responses. Random variation between muscle biopsy sites and measuring time points (Lexell and Taylor, 1991) might contribute to these highly variable responses. Ideally, data from immunohistochemical staining on cross-sections is confirmed with MRI, DEXA or ultrasound scans. We acknowledge that not having a second hypertrophy indicator is a limitation of the present study. It is, however, known that the hypertrophic/anabolic response to RT varies between individuals, both in older as in younger adults (Ahtiainen et al., 2016) . Importantly, training did decrease the frequency of type IIax fibres and a trend was observed towards less type IIx fibres as well, which is well documented in literature (Andersen and Aagaard, 2010) (Williamson et al., 2001) . This indicates that the type II fibre size analysis, comprising of all subtypes of type II fibres, was influenced by the different fibre type distribution across time. As muscle strength and power increased in all subjects independent of fibre size changes, other factors than fibre hypertrophy may have contributed to these strength gains, including the decreased frequency of type IIax fibres or other factors we did not measure (such as neural adaptations (Dankel et al., 2019) , tendon modifications (Brumitt and Cuddeford, 2015) and muscle architectural changes (Seynnes et al., 2007) ).
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Similar to fibre size parameters, Pax7+ SC and myonuclear number failed to increase significantly by the initial training period. However, we observed a trend towards more Pax7+ SCs in type I fibres as four of the six subjects displayed an increase in the number of SCs of +28 to +136 % following training. Although the trend-level was not reached in type II fibres, also here we noticed that Pax7+ SC levels were elevated in five of the six subjects (+16 to +225 %). The two subjects presenting stable (+3 %) or decreased (-15 %) Pax7+ SC levels in type I fibres, demonstrated increased SC levels in type II fibres (+128 % and +48 %, respectively), indicating that all six subjects experienced an increase in SCs of at least 16 % in one of the two fibre types following training. The large individual variability in SC responses resulted in non-significant findings in this small study. As shown in mice, SCs are indispensable for long-term functional muscle growth (Egner et al., 2016; Fry et al., 2014; Goh and Millay, 2017) and RT-induced muscle hypertrophy in elderly men is normally accompanied by an increase in the SC content, especially in type II fibres (Leenders et al., 2013; Verdijk et al., 2009 ). The ability to expand the SC pool appears to be related to the extent of muscle growth (Petrella et al., 2008) and also in the present study, subjects displaying a higher increase in type II Pax7+ SC number also demonstrated larger type II fibre growth.
We report a trend towards a decreased type II fibre size following detraining, which was found significant when type IIa fibres were analysed separately. Most detraining studies report atrophy across all fibre types in older adults (Hakkinen et al., 1985; Taaffe and Marcus, 1997) . But since fast-twitch type II fibres are more stimulated by high-intensity RT than slow-twitch type I fibres (Fry AC, 2004) , it is not unexpected that type II fibres are most affected by removing the training stimulus (Hakkinen et al., 1985; Staron et al., 1991) . Four out of six subjects displayed a loss in type II fibre size of -21 to -38 %. For three of them, type II fibre growth of +16 to +38 % was observed following the first training period and type II fibre atrophy following detraining could therefore be interpreted as a return to baseline. It does not seem plausible that decreases below baseline level are the result of detraining, as the detraining phase consisted of normal physical activity. This is rather due to the variability between biopsy sites within a muscle or between the same muscles of opposing legs Taylor, 1991, 1989) . Similar to the trend in decreased type II fibre size, we observed a trend towards less type II Pax7+ SCs following detraining compared to post-training. At the individual level, we observe that this decrease in Pax7+ SC number is simply a return to baseline level after a boost in Pax7+ SC levels following training. This is in accordance with literature in young men, showing a return of the training-elevated number of SCs to baseline level after 90 days of detraining (Kadi et al., 2004) . However, the type II Pax7+ SC level response was not uniform among all subjects in the EXE group, hence we cannot confirm this finding at group level.
It has been observed that acquired myonuclei are not lost during surgically-or mechanically-induced atrophy in rodents (reviewed by (Gundersen, 2016; Schwartz, 2019) ). As we did not observe myonuclear addition following the first training period, we could not investigate this hypothesis during detraining in older humans. However, type II fibre size and myonuclear number followed a similar track at the individual subject level, as both parameters were correlated during training and detraining. Naturally, there was no perfect overlap, which indicates that the MND can be flexible to adapt to fibre size adaptations as supported by literature (Murach et al., 2018a (Murach et al., , 2018b . Given that in subjects who displayed a J o u r n a l P r e -p r o o f decrease in type II CSA following detraining, we also counted less type II myonuclei, we hypothesize that the MND ultimately returns to its untrained state. This is already confirmed by recent studies, showing that the training-induced elevated myonuclear number returns to baseline level following twelve weeks of detraining in mice and following one year of detraining in older adults (Snijders et al., 2019) . Recently, Psilander et al. encountered limited fibre hypertrophy and no significant gain in myonuclei after ten weeks of RT in 19 young men and women (Psilander et al., 2019) . A reanalysis of these data highlighted the variability in the training response between individuals . This reanalysis identified seven individuals who definitely demonstrated myonuclear accretion following training and six of them lost the additional myonuclei during twenty weeks of detraining. Myonuclear changes corresponded well with the changes in muscle fibre volume, confirming the transient nature of gained myonuclei in the long-term also in younger adults. This study confirms the importance of observing the individual tracks, as group-level statistics can mask underlying patterns in subgroups or can be underpowered, as in the present study. Therefore, we presented trends in individual data as well. Altogether, this indicates that myonuclear loss may occur at a slower pace than fibre atrophy, since myonuclear loss has mostly been reported during slow models of atrophy in humans (interruption of training while still maintaining daily life physical activities Murach et al., 2019; Psilander et al., 2019; Snijders et al., 2019) ), and not during fast or invasive ones in humans (Brooks et al., 2010; Dirks et al., 2014; Ohira et al., 1999; Snijders et al., 2014) and rodents (Aravamudan et al., 2006; Bruusgaard et al., 2012; Bruusgaard and Gundersen, 2008; Duddy et al., 2011; Wada et al., 2002; Winje et al., 2019) .
It is a limitation of the present study that fibre characteristics were not measured at week four or eight of the retraining period to detect rapid restorations in fibre size. Nevertheless, the present data does show that during the second training period, fibres were triggered into an anabolic state, as significant type II fibre hypertrophy was observed. This type II fibre hypertrophy was accompanied by a significant expansion of the type II Pax7+ SC pool and fusion of SCs with type II fibres, reflected by the increase in type II myonuclear number. This gives us reason to believe that the fibres could be more responsive to the second period of training, although no additional gains were seen compared to baseline or posttraining. Five of the six subjects displaying type II fibre growth following retraining, also increased their type II myonuclear number. This is in line with previous studies in older adults (Leenders et al., 2013; Verdijk et al., 2009) , although fibre hypertrophy has not always been associated with myonuclear addition in older adults (Mackey et al., 2007;  J o u r n a l P r e -p r o o f techniques. Finally, it should be investigated whether old myonuclei are being replaced by newer ones during training, which could lead to improved transcriptional efficacy during a second training period and therefore could explain the positive protein net balance during retraining. Future studies should also study the role of lasting epigenetic alterations associated with a first training period (Seaborne et al., 2018; Turner et al., 2019) .
To conclude, twelve-weeks of RT induced muscle strength and power gains and decreased the frequency of type IIax fibres, as expected. A detraining period of similar length did not fully revert muscle strength and power and fibre type changes to pre-training levels. Thereby we add new information to the field in terms of reported power changes following twelve weeks of training and detraining. Although we were unable to test our initial hypothesis whether training-induced myonuclear accretion is maintained during twelve weeks of detraining in older men, we observed that changes in type II myonuclear number were positively correlated with changes in type II cross-sectional area during training, detraining and retraining in six older men. Based on observing the individual subject tracks and recent literature, we propose that myonuclei might be retained during rapid forms of atrophy, but that in the long-term, the MND is restored to its untrained steady-state. Despite the limited muscle sample size, we observed a rapid return in dynamic 1RM strength following retraining accompanied by type II fibre hypertrophy and an increase in type II Pax7+ SC and myonuclear number.
Although no additional improvements were found for SPT, PP, IKPT and fibre size compared to post-training level, previously trained muscles from older adults tended to be more responsive to RT than untrained muscles. Finally, we are the first to describe PCM1-labelled myonuclear counts in older men and report a higher number of myonuclei per fibre and smaller MNDs compared to conventional labelling methods. 
